Edap Tms (NASDAQ:EDAP) used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play robotic focal therapy company,” with management emphasizing the company’s...
Edap Tms (NASDAQ:EDAP) reported what management described as a “strong first quarter” for 2026, highlighted by record first-quarter revenue and continued momentum in its high-intensity focused ultrasound...
The HIFI Study shows HIFU offers comparable efficacy and improved functional outcomes versus radical prostatectomy for localized prostate cancer.Quiver AI SummaryEDAP TMS SA announced the publication of...
EDAP TMS reports successful ex vivo histotripsy lesion generation using Focal One® technology, promoting innovation in non-invasive therapies.Quiver AI SummaryEDAP TMS SA has announced a successful presentation...
Rockwell Medical RMTI is scheduled to report third-quarter 2024 results on Nov. 11, before the opening bell.In the last reported quarter, the company’s adjusted earnings of 1 cent exceeded the Zacks...
Good times continue for Rockwell Medical RMTI stock. Back-to-back big announcements over the recent months, like the company’s new launches for home hemodialysis, a multi-million-dollar distribution...
EDAP TMS EDAP has taken a significant step toward expanding its AI-assisted prostate cancer care through a strategic collaboration with AI healthcare company Avenda Health. This partnership is centered...
Rockwell Medical RMTI delivered an impressive performance through 2024, with its stock witnessing more than 108% year-to-date surge, outperforming the 15.5% rise of the industry and the benchmark’s 18.1%...
Company to host conference call and webcast on Thursday, August 25th at 8:30 am EDT LYON, France, August 3, 2022 - EDAP TMS SA (Nasdaq: EDAP), the...